This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Katsnelson, A. Next-generation proteasome inhibitor approved in multiple myeloma. Nat Biotechnol 30, 1011–1012 (2012). https://doi.org/10.1038/nbt1112-1011
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt1112-1011